Address: 2 Avtozavodskaya
Tel: +38 0445862064
Web: http://nobel.com.ua/
The company NOBEL company NOBEL was founded in 1964 as producing, and selling drugs marketiruyuschaya preparty. In 1978 it became part of the holding ULKAR . Today, ULKAR HOLDING , with its highly qualified staff in 2100, is a multinational pharmaceutical company with headquarters in Istanbul, Turkey.
ULKAR HOLDING consists of:
– Research and Development Center ( FARGEM )
– The production capacity in Turkey ( ULKAR KIMIYA and NOBELFARMA ), Kazakhstan ( NOBEL AFF ) and Uzbekistan ( NOBEL PHARMSANOAT )
– Marketing, promotion and sales organization in Turkey ( NOBEL operates in Turkey with a commando of 850 medical representatives), as well as in 14 countries in Eastern Europe, Central Asia and CIS
– The EU regulatory company located in Germany ( GENERINOBEL )
Drugs that are manufactured and marketiruyutsya by companies within the holding company, are presented in the following treatment groups:
– Analgesics – antipyretics
– Anti-inflammatory and antirheumatic
– Antimicrobials
– Allergy
– Preparations for the treatment of cardiovascular disease
– Cough medicines
– Preparations for the treatment of gastrointestinal diseases
– Preparations for the treatment of genitourinary system
– Preparations for the support of cancer
– Psychiatry
– Diseases of the respiratory tract
Igor Bondarenko of Ukraine’s Dnipro State Medical University, Evgeny Levenko from clinical trials company, ARENSIA, and Olena Popova from IQVIA offer their perspectives on maintaining quality and ensuring participant protection…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of the Russian invasion. Here, Chieko…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of the Russian invasion. Anina Adelfio…
Russia’s invasion of Ukraine has been roundly condemned by the pharmaceutical industry and almost all Big Pharmas have pledged humanitarian support to Ukraine. However, not all companies have followed the…
Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant corruption has been well received by the pharma MNCs operational in the country, but faces…
Vladimir Sayenko, founding partner, and Anzhela Makhinova, counsel, of the leading Ukrainian law firm Sayenko Kharenko, give an overview on the Ukrainian pharmaceutical industry in 2017 and explain the expansion…
Tetiana Korotchenko, Country Representative of Crown Agents, one of the three international organizations contracted by the Ukrainian government to temporarily handle healthcare procurement and put an end to the plague…
Dmytro Popov, the owner, founder and CEO Elfa Group, Ukraine’s leading cosmetics manufacturer, provides his insight into Elfa’s 20-year presence in the Ukrainian market, the company’s international growth strategies and…
Dr. Maxim Sokolov, chief external specialist of the Ministry of Health of Ukraine in cardiology, principal scientist of the Department of Interventional Cardiology of the National Academy of Medical Sciences…
Dr. Paul Melekhov, vice president Eastern Europe at Pharmascience, Canada’s third largest generic company, provides insights into the unique history of Pharmascience in Ukraine and the pioneering market approach that…
Julia Sidorova, country manager of Alvogen, a new international player to the Ukrainian market, provides insights into the targeted strategy that Alvogen employs throughout the world and how this is…
Victoria Filatova, president and chairperson of the Association of Perfumery and Cosmetics of Ukraine (APCU), discusses her strategic priorities, the association’s main achievements in its six years of existence, and…
See our Cookie Privacy Policy Here
